MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

NCT01443065 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm of Esophagus
Malignant Neoplasm of Stomach

Interventions

DRUG: Oxaliplatin
DRUG: Folinic Acid
DRUG: 5-fluoro-uracil
DRUG: panitumumab
DRUG: AMG102

Sponsor

UNICANCER